ENSC

Ensysce Biosciences, Inc.

Healthcare · Biotechnology

$207.13 sample

+3.32 (+1.63%) 1D

Market cap

$809.4B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-06

Alerts

8

Price$207.13 +8.16% 3M daily closessample

209.31188.59

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 06SEC10-Q filed
Sep 28SECDEF 14A filed
Sep 18INSInsider sell: 10% owner
Sep 11SECForm 144 filed
Sep 02INSInsider buy: Chief Executive Officer
Aug 28INSInsider buy: 10% owner
Aug 19INSInsider buy: Chief Financial Officer
Aug 13SEC10-Q filed

Sign up to see the real ENSC record →

Company facts

SEC EDGAR registration

Name: Ensysce Biosciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -26sample, -100 to +100
Reporting currency: USD

Who is positioning in ENSC

sample

Insiders: 34 insider transactions over 90 days, net selling, $336.2M
Congress: 2 members traded over 90 days
Institutions · 13F: 26 funds hold $8.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$32.1B +21.2% y/y

Q4 2024Q3 2026

Inventory$19.5B +21.1% y/y

Q4 2024Q3 2026

Accounts receivable$14.1B +14.0% y/y

Q4 2024Q3 2026

Total debt$36.9B +13.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $255.1B +1.3% 3M
Sample peer B: $650.6B +10.1% 3M
Sample peer C: $712.6B +13.7% 3M
Sample peer D: $699.7B -4.4% 3M
Sample peer E: $337.8B -0.7% 3M